Core Viewpoint - AtaiBeckley Inc has appointed Michael Faerm as Chief Financial Officer, effective March 9, 2026, to lead the company's financial strategy and operations as it advances its clinical-stage programs, particularly BPL-003 moving toward Phase 3 [1][4]. Group 1: Executive Appointment - Michael Faerm brings over 25 years of experience in life sciences, equity research, and investment banking to his new role as CFO [2]. - Anne Johnson, the current CFO since 2024, will transition to Chief Accounting Officer, ensuring continuity in financial operations [3]. Group 2: Company Strategy and Pipeline - AtaiBeckley focuses on developing rapid-acting, durable mental health treatments, with a pipeline that includes BPL-003 for treatment-resistant depression, VLS-01 for treatment-resistant depression, and EMP-01 for social anxiety disorder [5]. - BPL-003 is currently in Phase 3 planning, while VLS-01 and EMP-01 are in Phase 2 clinical development [5].

Delisting Announcements - Nasdaq announced the delisting of Advanced Health Intelligence Ltd.'s American Depositary Shares, which were suspended on July 30, 2024, and have not traded since [1] - The ordinary shares and warrants of noco-noco Inc. will also be delisted, with suspension occurring on November 25, 2024 [1] - LuxUrban Hotels Inc.'s common and preferred stock will be delisted, suspended since January 17, 2025 [2] - SRIVARU Holding Limited's Class A ordinary shares and warrants will be delisted, suspended since January 22, 2025 [2] - Hudson Acquisition I Corp.'s common stock, unit, and rights will be delisted, suspended since January 24, 2025 [3] - Plum Acquisition Corp III's Class A ordinary shares, units, and warrants will be delisted, suspended since January 28, 2025 [3] - QT Imaging Holdings, Inc.'s common stock will be delisted, suspended since January 28, 2025 [4] - Procaps Group, S.A.'s ordinary shares and warrants will be delisted, suspended since February 4, 2025 [4] - Viracta Therapeutics, Inc.'s common stock will be delisted, suspended since February 4, 2025 [5] - Stryve Foods, Inc.'s common stock and warrants will be delisted, suspended since February 6, 2025 [5] - Alternus Clean Energy, Inc.'s Class A common stock will be delisted, suspended since February 12, 2025 [6] - T2 Biosystems, Inc.'s common stock will be delisted, suspended since February 12, 2025 [6] - Staffing 360 Solutions, Inc.'s common stock will be delisted, suspended since February 13, 2025 [7] - Bio-Path Holdings, Inc.'s common stock will be delisted, suspended since February 19, 2025 [7] - FutureTech II Acquisition Corp.'s Class A common stock, warrants, and units will be delisted, suspended since February 26, 2025 [8] - Valuence Merger Corp I's Class A ordinary shares, units, and warrants will be delisted, suspended since March 11, 2025 [8] - Cutera, Inc.'s common stock will be delisted, suspended since March 13, 2025 [9] - Patria Latin American Opportunity Acquisition Corp.'s Class A Ordinary Shares will be delisted, suspended since March 19, 2025 [10] - Goldenstone Acquisition Limited's common stock, warrants, rights, and units will be delisted, suspended since March 26, 2025 [11] - Benson Hill, Inc.'s common stock will be delisted, suspended since March 27, 2025 [11] - 23andMe Holding Co.'s Class A common stock will be delisted, suspended since March 31, 2025 [12] - Global Lights Acquisition Corp's ordinary shares, units, and rights will be delisted, suspended since April 7, 2025 [12] - Metal Sky Star Acquisition Corporation's ordinary shares, warrants, rights, and units will be delisted, suspended since April 9, 2025 [13]